|
Acinetobacter baumannii
|
1
|
|
Aerosol Performance
|
3
|
|
Antibacterial
|
13
|
|
Antimicrobial Synergy
|
1
|
|
Bactericidal
|
2
|
|
bioaerosols
|
2
|
|
Biopharmaceutical Manufacturing
|
11
|
|
Cell Biology
|
9
|
|
Cell Targeting
|
9
|
|
cell therapy
|
5
|
|
Chemistry and Chemical Analysis
|
185
|
|
Colistin
|
3
|
|
Cystic Fibrosis
|
2
|
|
Drug Development
|
67
|
|
Drug Manufacturing
|
14
|
|
Drug Resistance
|
22
|
|
Dry Powder
|
1
|
|
Dry Powder Inhaler
|
3
|
|
Formulation
|
2
|
|
freeze drying
|
4
|
|
Gram-Negative
|
2
|
|
Industrial Crystallization
|
2
|
|
Inhaler
|
1
|
|
Klebsiella pneumonia
|
1
|
|
Lung Infection
|
1
|
|
Medical/Health
|
133
|
|
Medicinal Chemistry
|
23
|
|
Medicine
|
1
|
|
Meropenem
|
1
|
|
Micro & Nanotechnologies
|
78
|
|
Multi-drug Resistant Bacteria
|
3
|
|
Patient Care
|
17
|
|
Pharmaceutical Analysis
|
10
|
|
Pharmaceuticals
|
155
|
|
Pharmacology
|
9
|
|
Polymyxin
|
2
|
|
Pseudomonas aeruginosa
|
1
|
|
Pulmonary
|
1
|
|
Respiratory Infection
|
3
|
|
Spray Drying
|
1
|
